Clinical therapy for re-bleeding after endoscopic sinus hemostasis

Objective To explore the technique and curative effect of nasal endoscopic treatment for re-bleeding after nasal hemostasis.

Methods Clinical data of patients with rebleeding after nasal endoscopic nasal hemostasis in otolaryngology head and neck surgery department of the People' hospital of Rugao from January 2014 to January 2021 who met the selection criteria To retrospectively analyze the. Follow-up for 3 months, the high risk factors for bleeding was analyzed, the effect of nasal hemostasis under nasal endoscopy was observed, and the technical points were summarized.

Results A total of 53 patients with rebleeding after nasal hemostasis under nasal endoscopy were enrolled, aged from 31 to 79 years old, with an average age of 58.6 years, including 10 females (18.87%) and 43 males (81.13%). Rebleeding occurred 0.5 h-30 d after the first hemostasis under nasal endoscopy. Among them, bleeding occurred within 24 h in 25 cases (47.18%), 24-72 h in 12 cases (22.64%), 72 h-7 d in 8 cases (15.09%), and 7-30 d in 8 cases (15.09%). All patients underwent nasal hemostasis under nasal endoscopy again. The success rate of immediate hemostasis was 100%. A small amount of bleeding occurred in 2 cases after 3 months of follow-up. The bleeding stopped after treatment, and no active bleeding occurred in the rest of the patients.

Conclusions Re-bleeding after nasal hemostasis under nasal endoscopy can be effectively treated with nasal endoscopy.